Survival benefit of adjuvant chemotherapy in patients with resected gallbladder adenocarcinoma: An updated retrospective cohort analysis
Authors:
- Yizhi WangYWYizhi Wang
- Yang KongYKYang Kong
- Qifan YangQYQifan Yang
- Cheng ZhongCZCheng Zhong
- Dongkai ZhouDZDongkai Zhou
- Weilin WangWWWeilin Wang
- 21 February 2024
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 50 (4) , 108047
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 30 references indexed in Scilit:
- A meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinomaRadiation Oncology, 2020
- Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 studyThe Lancet Oncology, 2019
- Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice GuidelineJournal of Clinical Oncology, 2019
- Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III StudyJournal of Clinical Oncology, 2019
- Gallbladder CancerJAMA, 2018
- Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)International Journal of Surgery, 2018
- SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaJournal of Clinical Oncology, 2015
- Treatment and Prognosis for Patients With Intrahepatic CholangiocarcinomaJAMA Surgery, 2014
- The use of propensity score methods with survival or time‐to‐event outcomes: reporting measures of effect similar to those used in randomized experimentsStatistics in Medicine, 2013
- X-TileClinical Cancer Research, 2004